Opposite Effects of ? and ? Opioid Receptor Agonists on the In Vitro Release of Substance P-Like Material from the Rat Spinal Cord

1987 ◽  
Vol 48 (2) ◽  
pp. 529-537 ◽  
Author(s):  
Annie Mauborgne ◽  
Olivier Lutz ◽  
Jean-Claude Legrand ◽  
Michel Hamon ◽  
Frangois Cesselin
2002 ◽  
Vol 441 (1-2) ◽  
pp. 47-55 ◽  
Author(s):  
Annie Mauborgne ◽  
Harry Poliénor ◽  
Michel Hamon ◽  
François Cesselin ◽  
Sylvie Bourgoin

2021 ◽  
Author(s):  
Nicholas S. Akins ◽  
Nisha Mishra ◽  
Hannah M. Harris ◽  
Narendar Dudhipala ◽  
Seong Jong Kim ◽  
...  

Analgesia is commonly mediated through the mu or kappa opioid receptor agonism. Unfortunately, selective mu or kappa receptor agonists often cause harmful side effects. Recently, ligands exhibiting dual agonism to the opioid receptors, such as to mu and kappa, or to mu and delta, have been suggested to temper undesirable adverse effects while retaining analgesic activity. Herein we report an introduction of various 6,5-fused rings to C2 of the salvinorin scaffold <i>via</i> an ester linker. <i>In vitro</i> studies showed that some of these compounds have dual agonism on kappa and mu opioid receptors, while some have triple agonism on kappa, mu, and delta. <i>In vivo </i>studies on the lead dual kappa and mu opioid receptor agonist, compound <b>10</b>, showed that it<b> </b>produced analgesic activity while avoiding anxiogenic effects in murine models, thus providing further strong evidence for the therapeutic advantages of dual opioid receptor agonists over selective opioid receptor agonists.


2019 ◽  
Vol 4 (7) ◽  
pp. 2109-2115
Author(s):  
Elisabetta Maria Usai ◽  
Ilaria Manca ◽  
Francesca Pettinau ◽  
Antonio Mastino ◽  
Barbara Pittau

1999 ◽  
Vol 126 (2) ◽  
pp. 451-456 ◽  
Author(s):  
Minoru Narita ◽  
Hirokazu Mizoguchi ◽  
Michiko Narita ◽  
Ichiro Sora ◽  
George R Uhl ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document